Gain Net Tangible Assets vs Intangible Assets Analysis

GANX Stock

USD 1.47 0.03 2.08%

Gain Therapeutics financial indicator trend analysis is much more than just examining Gain Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gain Therapeutics is a good investment. Please check the relationship between Gain Therapeutics Net Tangible Assets and its Intangible Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Gain Stock please use our How to Invest in Gain Therapeutics guide.

Net Tangible Assets vs Intangible Assets

Net Tangible Assets vs Intangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gain Therapeutics Net Tangible Assets account and Intangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Gain Therapeutics' Net Tangible Assets and Intangible Assets is -0.37. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Gain Therapeutics, assuming nothing else is changed. The correlation between historical values of Gain Therapeutics' Net Tangible Assets and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Gain Therapeutics are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Net Tangible Assets i.e., Gain Therapeutics' Net Tangible Assets and Intangible Assets go up and down completely randomly.

Correlation Coefficient

-0.37

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Most indicators from Gain Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gain Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gain Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Gain Stock please use our How to Invest in Gain Therapeutics guide.At this time, Gain Therapeutics' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 184.75 in 2025, whereas Selling General Administrative is likely to drop slightly above 6.1 M in 2025.

	2022	2023	2024	2025 (projected)
Reconciled Depreciation	64.2K	78.1K	84.1K	88.3K
Total Operating Expenses	17.9M	22.3M	20.4M	12.8M

Reconciled Depreciation Total Operating Expenses

Gain Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment
Total Assets		0.13	0.71	0.76	1.0	0.91	0.96	0.96	-0.93	-0.57	0.7	0.93	0.69	0.78	0.8	1.0	0.35	0.53	0.28	0.68	0.78	0.81	1.0	0.91	0.6	0.47
Short Long Term Debt Total	0.13		-0.27	-0.25	0.15	-0.19	-0.01	0.3	-0.13	0.42	-0.15	0.16	0.17	-0.05	-0.09	0.14	-0.48	-0.47	0.93	-0.16	-0.25	-0.08	0.12	-0.09	-0.38	0.51
Other Current Liab	0.71	-0.27		0.97	0.65	0.69	0.82	0.58	-0.56	-0.91	0.9	0.55	0.59	0.85	0.83	0.69	0.69	0.9	-0.09	0.89	0.98	0.96	0.7	0.92	0.86	-0.17
Total Current Liabilities	0.76	-0.25	0.97		0.7	0.73	0.83	0.66	-0.59	-0.87	0.95	0.58	0.62	0.87	0.86	0.73	0.61	0.83	-0.09	0.93	0.95	0.98	0.75	0.95	0.81	-0.13
Total Stockholder Equity	1.0	0.15	0.65	0.7		0.91	0.94	0.96	-0.94	-0.51	0.64	0.95	0.68	0.73	0.76	1.0	0.3	0.48	0.29	0.62	0.73	0.75	1.0	0.87	0.55	0.53
Other Liab	0.91	-0.19	0.69	0.73	0.91		0.92	0.82	-0.91	-0.6	0.65	0.91	0.49	0.81	0.86	0.91	0.46	0.68	0.01	0.55	0.77	0.73	0.92	0.82	0.65	0.47
Net Tangible Assets	0.96	-0.01	0.82	0.83	0.94	0.92		0.85	-0.92	-0.69	0.72	0.92	0.6	0.83	0.84	0.96	0.49	0.71	0.17	0.72	0.9	0.86	0.96	0.93	0.72	0.38
Property Plant And Equipment Net	0.96	0.3	0.58	0.66	0.96	0.82	0.85		-0.86	-0.41	0.68	0.87	0.74	0.71	0.74	0.96	0.18	0.36	0.41	0.6	0.62	0.73	0.96	0.82	0.45	0.52
Net Debt	-0.93	-0.13	-0.56	-0.59	-0.94	-0.91	-0.92	-0.86		0.47	-0.46	-1.0	-0.41	-0.7	-0.72	-0.95	-0.34	-0.48	-0.32	-0.47	-0.68	-0.64	-0.95	-0.76	-0.54	-0.67
Retained Earnings	-0.57	0.42	-0.91	-0.87	-0.51	-0.6	-0.69	-0.41	0.47		-0.75	-0.46	-0.33	-0.75	-0.7	-0.55	-0.91	-0.88	0.16	-0.78	-0.9	-0.84	-0.57	-0.8	-0.98	0.3
Accounts Payable	0.7	-0.15	0.9	0.95	0.64	0.65	0.72	0.68	-0.46	-0.75		0.46	0.75	0.86	0.86	0.67	0.48	0.73	-0.04	0.87	0.83	0.94	0.68	0.88	0.68	-0.16
Cash	0.93	0.16	0.55	0.58	0.95	0.91	0.92	0.87	-1.0	-0.46	0.46		0.41	0.7	0.71	0.95	0.33	0.47	0.35	0.46	0.67	0.64	0.95	0.76	0.53	0.67
Non Current Assets Total	0.69	0.17	0.59	0.62	0.68	0.49	0.6	0.74	-0.41	-0.33	0.75	0.41		0.51	0.54	0.66	0.03	0.31	0.11	0.65	0.54	0.64	0.66	0.71	0.29	0.05
Non Currrent Assets Other	0.78	-0.05	0.85	0.87	0.73	0.81	0.83	0.71	-0.7	-0.75	0.86	0.7	0.51		0.99	0.75	0.59	0.84	0.17	0.66	0.85	0.9	0.78	0.83	0.75	0.2
Other Assets	0.8	-0.09	0.83	0.86	0.76	0.86	0.84	0.74	-0.72	-0.7	0.86	0.71	0.54	0.99		0.77	0.53	0.81	0.11	0.64	0.82	0.88	0.8	0.82	0.7	0.25
Cash And Short Term Investments	1.0	0.14	0.69	0.73	1.0	0.91	0.96	0.96	-0.95	-0.55	0.67	0.95	0.66	0.75	0.77		0.34	0.51	0.29	0.66	0.77	0.78	1.0	0.89	0.59	0.5
Net Receivables	0.35	-0.48	0.69	0.61	0.3	0.46	0.49	0.18	-0.34	-0.91	0.48	0.33	0.03	0.59	0.53	0.34		0.81	-0.16	0.45	0.7	0.58	0.35	0.53	0.95	-0.29
Common Stock Shares Outstanding	0.53	-0.47	0.9	0.83	0.48	0.68	0.71	0.36	-0.48	-0.88	0.73	0.47	0.31	0.84	0.81	0.51	0.81		-0.25	0.61	0.89	0.78	0.54	0.72	0.87	-0.14
Non Current Liabilities Total	0.28	0.93	-0.09	-0.09	0.29	0.01	0.17	0.41	-0.32	0.16	-0.04	0.35	0.11	0.17	0.11	0.29	-0.16	-0.25		-0.06	-0.06	0.09	0.28	0.07	-0.09	0.56
Other Current Assets	0.68	-0.16	0.89	0.93	0.62	0.55	0.72	0.6	-0.47	-0.78	0.87	0.46	0.65	0.66	0.64	0.66	0.45	0.61	-0.06		0.85	0.92	0.67	0.91	0.68	-0.25
Other Stockholder Equity	0.78	-0.25	0.98	0.95	0.73	0.77	0.9	0.62	-0.68	-0.9	0.83	0.67	0.54	0.85	0.82	0.77	0.7	0.89	-0.06	0.85		0.94	0.78	0.94	0.88	-0.03
Total Liab	0.81	-0.08	0.96	0.98	0.75	0.73	0.86	0.73	-0.64	-0.84	0.94	0.64	0.64	0.9	0.88	0.78	0.58	0.78	0.09	0.92	0.94		0.8	0.96	0.79	-0.03
Total Current Assets	1.0	0.12	0.7	0.75	1.0	0.92	0.96	0.96	-0.95	-0.57	0.68	0.95	0.66	0.78	0.8	1.0	0.35	0.54	0.28	0.67	0.78	0.8		0.9	0.6	0.49
Short Term Debt	0.91	-0.09	0.92	0.95	0.87	0.82	0.93	0.82	-0.76	-0.8	0.88	0.76	0.71	0.83	0.82	0.89	0.53	0.72	0.07	0.91	0.94	0.96	0.9		0.77	0.08
Common Stock	0.6	-0.38	0.86	0.81	0.55	0.65	0.72	0.45	-0.54	-0.98	0.68	0.53	0.29	0.75	0.7	0.59	0.95	0.87	-0.09	0.68	0.88	0.79	0.6	0.77		-0.19
Property Plant Equipment	0.47	0.51	-0.17	-0.13	0.53	0.47	0.38	0.52	-0.67	0.3	-0.16	0.67	0.05	0.2	0.25	0.5	-0.29	-0.14	0.56	-0.25	-0.03	-0.03	0.49	0.08	-0.19

Click cells to compare fundamentals

Gain Therapeutics Account Relationship Matchups

Gain Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	9.6M	39.0M	24.1M	18.6M	12.1M	16.5M
Short Long Term Debt Total	1.3M	1.6M	1.3M	1.0M	653.0K	837.8K
Other Current Liab	767.4K	1.2M	2.0M	2.1M	2.4M	1.4M
Total Current Liabilities	2.1M	2.6M	4.1M	4.9M	3.9M	3.0M
Total Stockholder Equity	6.2M	34.8M	18.9M	12.6M	7.3M	12.3M
Other Liab	132.2K	171.6K	329.5K	157.6K	181.2K	179.3K
Net Tangible Assets	(450.0K)	6.2M	34.6M	18.7M	21.5M	12.8M
Property Plant And Equipment Net	552.7K	1.0M	804.3K	585.2K	323.3K	596.8K
Net Debt	(6.2M)	(35.3M)	(6.0M)	(10.8M)	(9.7M)	(10.2M)
Retained Earnings	(7.0M)	(20.9M)	(38.5M)	(60.8M)	(81.2M)	(77.1M)
Accounts Payable	961.5K	560.5K	1.6M	1.3M	946.3K	898.4K
Cash	7.5M	36.9M	7.3M	11.8M	10.4M	11.7M
Non Current Assets Total	616.5K	1.3M	3.0M	830.5K	521.4K	495.3K
Non Currrent Assets Other	63.8K	53.4K	48.3K	51.9K	63.8K	46.1K
Other Assets	11.4K	63.8K	53.4K	48.3K	55.6K	41.4K
Cash And Short Term Investments	7.5M	36.9M	20.1M	16.8M	10.4M	14.5M
Net Receivables	66.6K	113.6K	103.9K	242.6K	765.8K	804.1K
Common Stock Shares Outstanding	11.9M	10.2M	11.9M	13.0M	22.9M	13.2M
Liabilities And Stockholders Equity	9.6M	39.0M	24.1M	18.6M	12.1M	16.5M
Non Current Liabilities Total	1.3M	1.6M	1.1M	1.1M	873.0K	1.2M
Other Current Assets	71.0K	343.1K	761.4K	984.2K	450.9K	437.8K
Other Stockholder Equity	13.4M	55.8M	57.4M	73.1M	88.8M	45.9M
Total Liab	3.4M	4.2M	5.2M	6.0M	4.8M	4.2M
Total Current Assets	9.0M	37.7M	21.1M	17.8M	11.6M	15.4M
Accumulated Other Comprehensive Income	(152.7K)	(90.6K)	35.6K	247.2K	(247.5K)	(235.2K)
Short Term Debt	145.4K	323.0K	337.2K	348.5K	271.1K	255.3K
Property Plant Equipment	219.3K	552.7K	1.0M	144.4K	166.0K	157.7K
Current Deferred Revenue	239.5K	266.5K	55.2K	1.1M	252.2K	422.5K
Capital Lease Obligations	523.1K	914.2K	670.9K	459.5K	214.5K	397.8K
Net Invested Capital	6.9M	35.5M	19.5M	13.1M	7.8M	15.1M
Property Plant And Equipment Gross	552.7K	1.0M	804.3K	678.0K	446.7K	679.8K
Net Working Capital	6.9M	35.2M	17.0M	12.8M	7.7M	14.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option

Additional Tools for Gain Stock Analysis

When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Gain Net Tangible Assets vs Intangible Assets Analysis

Net Tangible Assets vs Intangible Assets

Net Tangible Assets vs Intangible Assets Correlation Analysis

Correlation Coefficient

Net Tangible Assets

Intangible Assets

Gain Therapeutics fundamental ratios Correlations

Gain Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Gain Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Gain Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Cash	- 1.0	Net Debt
Common Stock	- 0.98	Retained Earnings
Total Current Assets	- 0.95	Net Debt
Cash And Short Term Investments	- 0.95	Net Debt
Net Debt	- 0.94	Total Stockholder Equity
Net Debt	- 0.93	Total Assets